 Connection
Search Results to Alison Oliveto
This is a "connection" page, showing the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of
Oliveto, Alison
| Property | Value |
|
overview
|
Historically, my career aims have been to improve upon treatments/ treatment access for substance use disorder as well as generally facilitate research in addiction and beyond. As a trained behavioral pharmacologist, I have had continuous NIH funding since 1993 conducting translational research in addiction, including human laboratory and clinical trials, with a focus on psychostimulant and/or opioid use disorders. In 1996 during my tenure at Yale School of Medicine, I established and directed the Outpatient Treatment Research Program at the West Haven CT Veterans Administration Healthcare System (VAHCS) that administratively involved three institutions (Yale, VAHCS, APT Foundation) to ensure the successful conduct of several medications development human laboratory and clinical trials. In 1998 I became Scientific Director of the NIDA P50 medications development center (T. Kosten, PI) and was responsible for coordinating the mentoring of physician scientists and fellows, overseeing research staff, and consolidating resources to maximize research productivity. When I accepted a faculty position at UAMS in 2004, I moved my research and established an addiction research program in the department of Psychiatry and became Vice Chair for Research in Psychiatry at UAMS. I have been responsible for intramural and extramural grant funding, overseeing the career development of clinician scientists, and establishing a research track for Psychiatry residents. I served in several leadership roles on campus, including in our CTSA-funded Translational Research Institute from 2014-2017. I directed the UAMS CTSA-supported Clinical Trials Unit, transforming culture and processes to maximize efficient, regulatory-compliant and rigorous conduct of multi-site trials. I became Director of Psychiatry's Center for Addiction Research in 2016 and have focused on strategic recruitment of addiction scientists as well as developing synergy among CAR/UAMS faculty. In 2020, I became the UAMS site principal investigator in the NIDA Clinical Trials Network Big/SouthWest Node and am awaiting funding on a NIDA CTN multi-site trial. Meanwhile, my focus has shifted to include drug prevention strategies and am currently leading the Arkansas State Epidemiological Outcomes Workgroup in partnership with state agencies, gathering, analyzing and disseminating trends in substance abuse and related outcomes in order to inform prevention efforts across the state.
|
|
research overview
|
A behavioral pharmacologist by training, I have been a funded NIH researcher for over four decades, conducting translational research focused mainly on opioid and/or stimulant use disorders. Much of my work has focused on developing human laboratory and clinical trial study designs that serve as models for studying efficacious treatments. For instance, I participated in the development and testing of a methodological advance in human drug discrimination procedures (novel-response option) and applied this methodological advance to a human laboratory model of opioid withdrawal, through which two nonopioid compounds were identified as potential opioid withdrawal treatments. Moreover, my Yale colleague, Dr. Patrick O’Connor, and I piloted the first trial of office-based buprenorphine treatment for opioid use disorder. In addition, I developed in collaboration with Dr. Thomas Kosten a relapse paradigm for stimulant use disorder trials and identified the SSRI sertraline as a potentially efficacious relapse prevention treatment. I also mentored Dr. Michael Mancino (UAMS) on the development of a rigorous amphetamine withdrawal paradigm for his COBRE project (PI: Garcia-Rill) and Dr. Michael Wilson (UAMS) on developing a human laboratory model of “agitation”, which often occurs among methamphetamine users presenting to the ED. I am currently leading the Arkansas Statewide Epidemiology Outcomes Workgroup, monitoring substance use trends and related outcomes to help guide successful substance use prevention efforts in the state. Along these lines, I have been working with Dr. Ronald Thompson (UAMS) on developing and testing the efficacy of an adolescent game-based nonmusical prescription drug use prevention intervention along with a caregiver educational component. Meanwhile, I have returned to my behavioral pharmacology roots, piloting the effects of cannabis in older adults.
|
One or more keywords matched the following items that are connected to
Oliveto, Alison
| Item Type | Name |
|
Concept
|
Arkansas
|
|
Academic Article
|
Telemedicine Interest for Routine Follow-Up Care Among Neurology Patients in Arkansas.
|
|
Grant
|
Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence
|
|
Grant
|
Expanding Access to Medication Assisted Treatment Across the State of Arkansas
|
|
Grant
|
Partnership for Success: Statewide Epidemiological Outcomes Workgroup for Arkansas
|
|
Grant
|
Expanding Translational Research in Arkansas
|
|
Award or Honor Receipt
|
RAAD Above & Beyond in Prevention Award
|
|
Academic Article
|
Clinical Researcher’s Handbook: A Survival Guide. Tips for maintaining research compliance and collecting high quality research data. Translational Research Institute, University of Arkansas for Medical Sciences
|
|
Academic Article
|
Safe prescribing of Opioids for Pain Management in Children and Adolescents: Tips for Healthcare Providers. University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services. University of Arkansas for Medical Sciences, Little Rock, AR
|
|
Academic Article
|
Pain Medicine Guide for Kids: How to safely use pain medicine. [Spanish version: Guía de Medicina para el Dolor para Niños: Cómo tomar medicina para el dolor de forma segura]. University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services. University of Arkansas for Medical Sciences, Little Rock, AR
|
|
Academic Article
|
Prescription Pain Medicine Guide for Teens: How to safely use prescription opioid medicines to treat your pain [Spanish version: Guía de Medicina para el Dolor Recetada para Adolescentes Cómo tomar medicinas de opioides recetadas para tratar tu dolor de forma segura]. University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services. University of Arkansas for Medical Sciences, Little Rock, AR
|
|
Academic Article
|
Helping Your Child Safely Take Prescription Pain Medicine: The Caregiver’s Guide [Spanish version: Ayudando a Su Niño a Tomar Medicina con Precaución, Recetada por el Dolor: La Guía para el Cuidador.] University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services
|
|
Academic Article
|
Medical Marijuana: What Arkansas Physicians Need to Know. University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services. University of Arkansas for Medical Sciences, Little Rock, AR
|
|
Academic Article
|
Using Methamphetamine (Meth): Know the Risks. [Spanish version: Usar Metanfetamina (Meta): Conozca los Riesgos.] University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services. University of Arkansas for Medical Sciences, Little Rock, AR
|
|
Academic Article
|
Most Arkansas Young Adults do not use Marijuana. [Spanish version: En Arkansas, la mayoría de los adultos jóvenes no usan marihuana]. University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services. University of Arkansas for Medical Sciences, Little Rock, AR
|
|
Academic Article
|
Most Teens in Arkansas do not use Marijuana. [Spanish version: La mayoría de los jovenes en Arkansas no usan marihuana]. University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services. University of Arkansas for Medical Sciences, Little Rock, AR
|
|
Academic Article
|
Medical Marijuana: What Arkansas Teens Need to Know [Spanish version: Marihuana Medicinal: Lo que los Adolescentes de Arkansas Necesitan Saber]. University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services. University of Arkansas for Medical Sciences, Little Rock, AR
|
|
Academic Article
|
Medical Marijuana: What Caregivers Need to Know [Spanish version: Lo que los cuidadores deben saber sobre la marihuana medicinal]. University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services. University of Arkansas for Medical Sciences, Little Rock, AR
|
|
Academic Article
|
Medical Marijuana: What Arkansas Adults Need to Know [Spanish version: Marihuana medicinal: lo que los adultos en Arkansas necesitan saber]. University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services. University of Arkansas for Medical Sciences, Little Rock, AR
|
|
Academic Article
|
Medical Marijuana: What Arkansas Kids Need to Know [Spanish version: Informacion Sobre La Marihuana Medicinal: lo que los ninos de Arkansas necesitan saber]. University of Arkansas for Medical Sciences, University of Arkansas at Little Rock MidSouth, and the Arkansas Department of Human Services. University of Arkansas for Medical Sciences, Little Rock, AR
|
|
Academic Article
|
Arkansas State Epidemiological Outcomes Workgroup: 2020 Arkansas State Epidemiological Profile of Substance Use. Little Rock: Psychiatric Research Institute, University of Arkansas for Medical Sciences
|
|
Academic Article
|
Arkansas State Epidemiological Outcomes Workgroup: A Companion Guide to the 2020 Arkansas State Epidemiological Profile of Substance Use. Regional Key Findings. Little Rock: Psychiatric Research Institute, University of Arkansas for Medical Sciences
|
|
Academic Article
|
Arkansas State Epidemiological Outcomes Workgroup: 2021 Arkansas Young Adult State of Wellbeing. Little Rock: Psychiatric Research Institute, University of Arkansas for Medical Sciences
|
|
Academic Article
|
Arkansas State Epidemiological Outcomes Workgroup: 2021 Arkansas State Epidemiological Profile of Substance Use. Little Rock: Psychiatric Research Institute, University of Arkansas for Medical Sciences. Downloadable from:
|
|
Academic Article
|
Arkansas State Epidemiological Outcomes Workgroup: 2022 Arkansas Young Adult State of Wellbeing. Little Rock: Psychiatric Research Institute, University of Arkansas for Medical Sciences
|
|
Academic Article
|
Arkansas State Epidemiological Outcomes Workgroup: 2022 Arkansas State Epidemiological Profile of Substance Use. Little Rock: Psychiatric Research Institute, University of Arkansas for Medical Sciences
|
|
Academic Article
|
Arkansas State Epidemiological Outcomes Workgroup: 2022 Arkansas Young Adult State of Wellbeing. Little Rock: Psychiatric Research Institute, University of Arkansas for Medical Sciences
|
|
Academic Article
|
Arkansas State Epidemiological Outcomes Workgroup: 2022 Arkansas Young Adult State of Wellbeing. Little Rock: Psychiatric Research Institute, University of Arkansas for Medical Sciences
|
|
Academic Article
|
Arkansas State Epidemiological Outcomes Workgroup: 2023 Arkansas State Epidemiological Profile of Substance Use. Little Rock: Psychiatric Research Institute, University of Arkansas for Medical Sciences
|
|
|